March 19, 2025
•Dr. Dimitri LivitzProgram to Optimize Cancer Drug Trials
NoRD Bio's team of experts in the assessment of tumor heterogeneity and evolution has launched a program to aid pharma and biotech companies in cancer drug development.
Read Full Article